Randomized controlled trials are underway, regulatory decisions lie ahead, and real-world data will continue to accumulate
[1] [3] Other considerations during the perioperative period may include: Potential for nausea and vomiting Challenges with airway management if emergency intubation is required Effects on post-operative recovery and nutrition Changes in blood glucose control Anaesthetists may modify their approach based on individual risk assessment, potentially including techniques to reduce aspiration risk or additional monitoring
[4] [6] The mechanism of action involves several complementary pathways
For Future Research Additional studies assessing the impact of GLP-1 receptor agonists on gastric emptying and their potential impact on fasting prior to endoscopic procedures are sorely needed
Advancements In GLP-1 Agonist Therapies For Diabetes And Weight Management GLP-1 agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists mimic naturally occurring incretin hormones to slow gastric emptying, increase the feeling of fullness, promote insulin secretion, and inhibit the inappropriate release of glucagon
Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity
